Evidence based cardiology: Prevention of ischaemic stroke
- 5 June 1999
- Vol. 318 (7197) , 1539-1543
- https://doi.org/10.1136/bmj.318.7197.1539
Abstract
Stroke is the second most common cause of death worldwide, exceeded only by heart disease.1 Coincident with the emergence of prevention strategies, incidence of stroke is declining dramatically in developed countries. The prevention of stroke is an obligation facing everyone involved with delivering health care. ### Summary points Managing the risk factors of hypertension, tobacco, and hyperglycaemia reduces the risk of stroke Managing hyperglycaemia will diminish the severity of strokes Warfarin prevents stroke in non-valvular atrial fibrillation Aspirin is the first choice of platelet inhibitors for stroke prevention Endarterectomy prevents stroke when symptoms are due to severe stenosis;with moderate stenosis the benefit is muted Endarterectomy is of uncertain benefit for asymptomatic carotid stenosis Prospective population studies and retrospective case series have identified modifiable risk factors important for ischaemic and haemorrhagic stroke. The Four Horsemen of the Apocalypse of stroke display the banners of hypertension, tobacco, diabetes mellitus, and hyperlipidaemia.2 All are responsible for cerebral arteriosclerosis. Transient ischaemic events are powerful predictors of stroke. Coronary artery disease and atrial fibrillation increase stroke risk. Compounds lowering cholesterol, the “statins,” reduce the risk of myocardial infarction and stroke.3 At no age and in neither sex is a systolic blood pressure above 160 mm Hg and a diastolic pressure above 90 mm Hg acceptable. Even elderly subjects and heavy smokers reduce the risk of stroke by abandoning cigarettes.4 Control of insulin dependent diabetes has not been shown to reduce stroke.5 A stroke in the presence of hyperglycemia is more disabling. Family history of stroke requires the Four Horsemen be sought and managed in the early decades of life. Fatalistic attitudes are wrong. Genetics deals the cards. The play can be determined by environmental influences. Coagulation abnormalities and homocysteinaemia add to the likelihood of early stroke but are manageable.6 Seven randomised trials …This publication has 52 references indexed in Scilit:
- Guidelines for Carotid EndarterectomyStroke, 1998
- A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial originAnnals of Neurology, 1997
- Fraud and Ethics Charges Hit Stroke Drug TrialScience, 1996
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Contrast sonography for detection of vesicoureteral refluxThe Lancet, 1994
- Efficacy of Carotid Endarterectomy for Asymptomatic Carotid StenosisNew England Journal of Medicine, 1993
- Vascular risks of asymptomatic carotid stenosis.Stroke, 1991
- Carotid endarterectomy--an expression of concern.Stroke, 1984
- Immediate anticoagulation of embolic stroke: a randomized trial. Cerebral Embolism Study Group.Stroke, 1983